Position in ANVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$28,784
-$5,726 QoQ
Shares Held
15,476
0.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 61 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ANVS ranks #299 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ANVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,784 | 15,476 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $34,510 | 15,476 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $69,399 | 20,058 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $39,449 | 19,058 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $41,354 | 19,058 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $28,586 | 19,058 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $95,861 | 19,058 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $153,614 | 19,059 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $109,778 | 19,059 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $226,801 | 19,059 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $387,183 | 20,705 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $320,495 | 33,772 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $487,673 | 34,127 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $527,376 | 34,223 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $459,614 | 34,223 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $470,307 | 34,329 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $289,078 | 25,492 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $340,758 | 25,525 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $543,273 | 30,903 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $826,642 | 26,036 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,897,137 | 22,168 | Shares | Other | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||